Table 1. Baseline Characteristics of the Newly Diagnosed Cancer Patients (2019–2020).
| 2019 (n=292808) | 2020 (n=283424) | ||
|---|---|---|---|
| Sex | |||
| Male | 142044 (48.5) | 137724 (48.6) | |
| Female | 150764 (51.5) | 145700 (51.4) | |
| Age (yr) | |||
| 0–39 | 26501 (9.1) | 26059 (9.2) | |
| 40–64 | 134627 (46.0) | 127304 (44.9) | |
| Over 65 | 131680 (45.0) | 130061 (45.9) | |
| Insurance type | |||
| Locally provided policyholders | 85417 (29.2) | 83193 (28.4) | |
| Employer-provided policyholders | 194170 (66.3) | 187382 (64.0) | |
| Recipient of medical benefits | 13221 (4.5) | 2849 (4.4) | |
| Residence | |||
| Capital | 139027 (47.5) | 135556 (47.8) | |
| Central | 40383 (13.8) | 38920 (13.7) | |
| Southeastern | 77859 (26.6) | 74403 (26.3) | |
| Southwestern | 35430 (12.1) | 34448 (12.2) | |
| - | 109 (-) | 97 (-) | |
| Location of healthcare facilities | |||
| Capital | 172641 (59.0) | 166186 (58.6) | |
| Central | 27663 (9.4) | 27434 (9.7) | |
| Southeastern | 65303 (22.3) | 63264 (22.3) | |
| Southwestern | 27201 (9.3) | 26540 (9.4) | |
| Income level | |||
| Group 1 (level 0–4) | 62112 (21.2) | 58853 (20.8) | |
| Group 2 (level 5–8) | 35413 (12.1) | 36475 (12.9) | |
| Group 3 (level 9–12) | 45784 (15.6) | 44783 (15.8) | |
| Group 4 (level 13–16) | 58863 (20.1) | 55809 (19.7) | |
| Group 5 (level 17–20) | 86382 (29.5) | 83439 (29.4) | |
| - | 4254 (1.5) | 4065 (1.4) | |
| Cancer type | |||
| Lip, oral cavity, and pharynx | 2776 (0.9) | 2860 (1.0) | |
| Gastrointestinal | 77703 (26.5) | 73093 (25.8) | |
| Lung and intrathoracic | 24263 (8.3) | 23243 (8.2) | |
| Bone and soft tissue | 8711 (3.0) | 8615 (3.0) | |
| Breast | 21959 (7.5) | 21831 (7.7) | |
| Gynecological | 23434 (8.0) | 23797 (8.4) | |
| Genitourinary | 12108 (4.1) | 12159 (4.3) | |
| Eye, brain, and other parts of central nervous system | 1886 (0.6) | 1835 (0.6) | |
| Thyroid | 28674 (9.8) | 27476 (9.7) | |
| Secondary and unspecified site | 16036 (5.5) | 15950 (5.6) | |
| Lymphoma | 11127 (3.8) | 11032 (3.9) | |
| Multiple sites | 17 (-) | 14 (-) | |
| In situ neoplasms | 25587 (8.7) | 24855 (8.8) | |
| Benign neoplasm of brain and other parts of central nervous system | 22668 (7.7) | 21718 (7.7) | |
| Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes | 15859 (5.4) | 15305 (5.4) | |
Data are presented as n (%).